Search

everythinglearnresearchcommunity

for

Search:↓

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

Mild essential fatty acid deficiency can cause health issues and is worsened by low-fat diets.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Men with a certain type of hair loss (vertex type AGA) may have higher levels of bad fats (triglycerides) and lower levels of good cholesterol (HDL), suggesting they could be at risk for high fat levels in the blood (hyperlipidemia).

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Bald men may have higher heart disease risk.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Early hair loss may be linked to metabolic syndrome.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Young adults with hair loss face higher risk of stiff arteries.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Early balding men may have insulin resistance, but lifestyle changes can help.

Isotretinoin affects trace element levels and requires monitoring of liver and kidney functions.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Finasteride may help treat kidney disease caused by a high-fat diet by reducing harmful toxins and improving gut bacteria.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.